Generative AI will be designing new drugs all on its own in the near future
It won't be long for artificial intelligence can handle drug discovery for pharmaceutical companies without human scientists. Source link
Read More
Pharmaceuticals
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Amgen's update fueled concerns about potential new competition in the weight loss drug market, sending shares of Novo Nordisk and
Read More
Wegovy maker Novo Nordisk down 4%, heads for worst day since October
Analysts pored over the details in its first-quarter results and monitored a potential rival weight loss treatment. Source link
Read More
Amgen scraps experimental weight loss pill, moves forward with injection
Amgen is among several drugmakers racing to join the red-hot weight loss drug space dominated by Novo Nordisk and Eli
Read More
Walgreens to help bring cell and gene therapies to patients as it expands specialty pharmacy services
Among the company's investments to "transform" its specialty pharmacy services is the opening of a new facility dedicated to cell
Read More
Swiss pharma giant Roche’s first-quarter sales edge higher as its emerges from post-Covid-19 slump
Roche lowered its 2024 growth outlook in February as it continues to confront a drop-off in demand for its Covid-19
Read More
Drugmaker Novartis climbs 4.4% after guidance rise on sales of blockbuster drugs
Shares of Swiss drugmaker Novartis climbed as much as 4.8% in early deals Tuesday after it raised its full-year guidance
Read More
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
The findings add to concerns that GLP-1s could take a bite out of the bottom lines of some of the
Read More
Eli Lilly’s weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trials
The pharmaceutical giant plans to present the trial data at an upcoming medical conference and submit them to the U.S.
Read More